Delphia (USA)’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,845
Closed -$94K 393
2022
Q2
$94K Buy
+11,845
New +$94K 0.06% 342